112 related articles for article (PubMed ID: 2061928)
1. Isoprenyl phosphinylformates: new inhibitors of squalene synthetase.
Biller SA; Forster C; Gordon EM; Harrity T; Rich LC; Marretta J; Ciosek CP
J Med Chem; 1991 Jun; 34(6):1912-4. PubMed ID: 2061928
[No Abstract] [Full Text] [Related]
2. Isoprenoid (phosphinylmethyl)phosphonates as inhibitors of squalene synthetase.
Biller SA; Forster C; Gordon EM; Harrity T; Scott WA; Ciosek CP
J Med Chem; 1988 Oct; 31(10):1869-71. PubMed ID: 3172121
[No Abstract] [Full Text] [Related]
3. Synthesis and biological evaluation of quinuclidine derivatives incorporating phenothiazine moieties as squalene synthase inhibitors.
Ishihara T; Kakuta H; Moritani H; Ugawa T; Yanagisawa I
Chem Pharm Bull (Tokyo); 2004 Oct; 52(10):1204-9. PubMed ID: 15467236
[TBL] [Abstract][Full Text] [Related]
4. Lipophilic 1,1-bisphosphonates are potent squalene synthase inhibitors and orally active cholesterol lowering agents in vivo.
Ciosek CP; Magnin DR; Harrity TW; Logan JV; Dickson JK; Gordon EM; Hamilton KA; Jolibois KG; Kunselman LK; Lawrence RM
J Biol Chem; 1993 Nov; 268(33):24832-7. PubMed ID: 8227045
[TBL] [Abstract][Full Text] [Related]
5. alpha-Phosphonosulfonic acids: potent and selective inhibitors of squalene synthase.
Magnin DR; Biller SA; Chen Y; Dickson JK; Fryszman OM; Lawrence RM; Logan JV; Sieber-McMaster ES; Sulsky RB; Traeger SC; Hsieh DC; Lan SJ; Rinehart JK; Harrity TW; Jolibois KG; Kunselman LK; Rich LC; Slusarchyk DA; Ciosek CP
J Med Chem; 1996 Feb; 39(3):657-60. PubMed ID: 8576905
[No Abstract] [Full Text] [Related]
6. Amidinium cation as a mimic of allylic carbocation: synthesis and squalene synthetase inhibitory activity of an amidinium analog of a carbocation intermediate.
Prashad M
J Med Chem; 1993 Mar; 36(5):631-2. PubMed ID: 8496942
[No Abstract] [Full Text] [Related]
7. The squalestatins: decarboxy and 4-deoxy analogues as potent squalene synthase inhibitors.
Chan C; Andreotti D; Cox B; Dymock BW; Hutson JL; Keeling SE; McCarthy AD; Procopiou PA; Ross BC; Sareen M; Scicinski JJ; Sharratt PJ; Snowden MA; Watson NS
J Med Chem; 1996 Jan; 39(1):207-16. PubMed ID: 8568810
[TBL] [Abstract][Full Text] [Related]
8. Squalene synthase inhibitors: their potential as hypocholesterolaemic agents.
Watson NS; Procopiou PA
Prog Med Chem; 1996; 33():331-78. PubMed ID: 8776946
[No Abstract] [Full Text] [Related]
9. Phenoxypropylamines: a new series of squalene synthase inhibitors.
Brown GR; Butlin RJ; Chapman S; Eakin MA; Foubister AJ; Freeman S; Griffiths D; Harrison PJ; Johnson MC; Mallion KB
J Med Chem; 1995 Oct; 38(21):4157-60. PubMed ID: 7473541
[No Abstract] [Full Text] [Related]
10. The squalestatins: novel inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C1-modified analogues.
Procopiou PA; Bailey EJ; Bamford MJ; Craven AP; Dymock BW; Houston JG; Hutson JL; Kirk BE; McCarthy AD; Sareen M
J Med Chem; 1994 Sep; 37(20):3274-81. PubMed ID: 7932554
[TBL] [Abstract][Full Text] [Related]
11. CJ-13,981 and CJ-13,982, new squalene synthase inhibitors.
Watanabe S; Hirai H; Kambara T; Kojima Y; Nishida H; Sugiura A; Yamauchi Y; Yoshikawa N; Harwood HJ; Huang LH; Kojima N
J Antibiot (Tokyo); 2001 Dec; 54(12):1025-30. PubMed ID: 11858656
[TBL] [Abstract][Full Text] [Related]
12. Squalene synthetase. Stoichiometry and kinetics of presqualene pyrophosphate and squalene synthesis by yeast microsomes.
Agnew WS; Popják G
J Biol Chem; 1978 Jul; 253(13):4566-73. PubMed ID: 26684
[No Abstract] [Full Text] [Related]
13. Syntheses and biological evaluation of novel quinuclidine derivatives as squalene synthase inhibitors.
Ishihara T; Kakuta H; Moritani H; Ugawa T; Sakamoto S; Tsukamoto S; Yanagisawa I
Bioorg Med Chem; 2003 May; 11(11):2403-14. PubMed ID: 12735986
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and activity of a novel series of 3-biarylquinuclidine squalene synthase inhibitors.
Brown GR; Clarke DS; Foubister AJ; Freeman S; Harrison PJ; Johnson MC; Mallion KB; McCormick J; McTaggart F; Reid AC; Smith GJ; Taylor MJ
J Med Chem; 1996 Jul; 39(15):2971-9. PubMed ID: 8709131
[TBL] [Abstract][Full Text] [Related]
15. Cyclopentanedi- and tricarboxylic acids as squalene synthase inhibitors: syntheses and evaluation.
Shen W; Garvey DS; Cohen J; Stein H; Rosenberg SH
Bioorg Med Chem Lett; 1998 Apr; 8(8):891-6. PubMed ID: 9871507
[TBL] [Abstract][Full Text] [Related]
16. Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors.
Griebenow N; Flessner T; Buchmueller A; Raabe M; Bischoff H; Kolkhof P
Bioorg Med Chem Lett; 2011 Apr; 21(8):2554-8. PubMed ID: 21396815
[TBL] [Abstract][Full Text] [Related]
17. 1-Hydroxy-3-(methylpentylamino)-propylidene-1,1-bisphosphonic acid as a potent inhibitor of squalene synthase.
Amin D; Cornell SA; Perrone MH; Bilder GE
Arzneimittelforschung; 1996 Aug; 46(8):759-62. PubMed ID: 9125274
[TBL] [Abstract][Full Text] [Related]
18. The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.
Procopiou PA; Cox B; Kirk BE; Lester MG; McCarthy AD; Sareen M; Sharratt PJ; Snowden MA; Spooner SJ; Watson NS; Widdowson J
J Med Chem; 1996 Mar; 39(7):1413-22. PubMed ID: 8691471
[TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.
Kourounakis AP; Charitos C; Rekka EA; Kourounakis PN
J Med Chem; 2008 Sep; 51(18):5861-5. PubMed ID: 18754614
[TBL] [Abstract][Full Text] [Related]
20. N-(arylalkyl)farnesylamines: new potent squalene synthetase inhibitors.
Prashad M; Kathawala FG; Scallen T
J Med Chem; 1993 May; 36(10):1501-4. PubMed ID: 8496919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
